Data is not available at this time.
ImageONE Co., Ltd. operates at the intersection of healthcare technology and environmental solutions, serving the Japanese market with a diversified portfolio. The company’s healthcare segment focuses on medical systems, including EHR/EMR software, PACS, diagnostic imaging equipment, and clinical management support, catering to hospitals and clinics. Its environmental division provides renewable energy solutions like solar panels and wind turbines, alongside innovative EV battery distribution and tritium-related technologies. This dual-sector approach positions ImageONE as a niche player addressing Japan’s aging healthcare infrastructure and green energy transition. The company’s expertise in radiation-tolerant cameras and water plasma treatment further differentiates it in specialized industrial applications. However, its market share remains modest compared to larger conglomerates in either sector, reflecting its role as a solutions provider rather than a dominant incumbent. The reliance on domestic demand and technological partnerships underscores both its agility and exposure to localized economic shifts.
In FY2024, ImageONE reported revenue of JPY 1.56 billion but faced significant challenges, with a net loss of JPY 889.6 million and negative operating cash flow of JPY 207.2 million. The diluted EPS of -JPY 82.92 reflects strained profitability, likely due to operational inefficiencies or sector-specific headwinds. Capital expenditures were minimal at JPY 5.7 million, suggesting limited near-term growth investments.
The company’s negative earnings and cash flow indicate weak capital efficiency, with no clear near-term path to operational breakeven. The absence of dividend payouts aligns with its focus on preserving liquidity, though the lack of profitability raises questions about sustainable returns on invested capital in its current structure.
ImageONE maintains a modest cash position of JPY 553.8 million against minimal total debt of JPY 16.2 million, implying a low-leverage balance sheet. However, the cash reserves may be insufficient to cover persistent operating losses without additional financing or restructuring, given the JPY 207.2 million annual cash burn.
Growth appears stagnant, with no dividends and negative earnings. The company’s focus on niche healthcare and environmental technologies may offer long-term potential, but current trends suggest limited scalability without strategic pivots or external funding.
With a market cap of JPY 2.51 billion and a beta of 0.42, ImageONE is priced as a high-risk micro-cap stock. Investors likely discount its prospects due to sustained losses, though its specialized offerings could attract interest if sector tailwinds materialize.
ImageONE’s dual-sector expertise provides diversification, but execution risks loom. Success hinges on commercializing its tritium and renewable energy technologies while stabilizing healthcare revenues. The outlook remains cautious unless operational turnaround or partnerships emerge.
Company description, financials from disclosed filings (unspecified), market data from exchange sources
show cash flow forecast
| Fiscal year | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 | 2036 | 2037 | 2038 | 2039 | 2040 | 2041 | 2042 | 2043 | 2044 | 2045 | 2046 | 2047 | 2048 | 2049 | |
INCOME STATEMENT | ||||||||||||||||||||||||||
| Revenue growth rate, % | NaN | |||||||||||||||||||||||||
| Revenue, $ | NaN | |||||||||||||||||||||||||
| Variable operating expenses, $m | NaN | |||||||||||||||||||||||||
| Fixed operating expenses, $m | NaN | |||||||||||||||||||||||||
| Total operating expenses, $m | NaN | |||||||||||||||||||||||||
| Operating income, $m | NaN | |||||||||||||||||||||||||
| EBITDA, $m | NaN | |||||||||||||||||||||||||
| Interest expense (income), $m | NaN | |||||||||||||||||||||||||
| Earnings before tax, $m | NaN | |||||||||||||||||||||||||
| Tax expense, $m | NaN | |||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
BALANCE SHEET | ||||||||||||||||||||||||||
| Cash and short-term investments, $m | NaN | |||||||||||||||||||||||||
| Total assets, $m | NaN | |||||||||||||||||||||||||
| Adjusted assets (=assets-cash), $m | NaN | |||||||||||||||||||||||||
| Average production assets, $m | NaN | |||||||||||||||||||||||||
| Working capital, $m | NaN | |||||||||||||||||||||||||
| Total debt, $m | NaN | |||||||||||||||||||||||||
| Total liabilities, $m | NaN | |||||||||||||||||||||||||
| Total equity, $m | NaN | |||||||||||||||||||||||||
| Debt-to-equity ratio | NaN | |||||||||||||||||||||||||
| Adjusted equity ratio | NaN | |||||||||||||||||||||||||
CASH FLOW | ||||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
| Depreciation, amort., depletion, $m | NaN | |||||||||||||||||||||||||
| Funds from operations, $m | NaN | |||||||||||||||||||||||||
| Change in working capital, $m | NaN | |||||||||||||||||||||||||
| Cash from operations, $m | NaN | |||||||||||||||||||||||||
| Maintenance CAPEX, $m | NaN | |||||||||||||||||||||||||
| New CAPEX, $m | NaN | |||||||||||||||||||||||||
| Total CAPEX, $m | NaN | |||||||||||||||||||||||||
| Free cash flow, $m | NaN | |||||||||||||||||||||||||
| Issuance/(repurchase) of shares, $m | NaN | |||||||||||||||||||||||||
| Retained Cash Flow, $m | NaN | |||||||||||||||||||||||||
| Pot'l extraordinary dividend, $m | NaN | |||||||||||||||||||||||||
| Cash available for distribution, $m | NaN | |||||||||||||||||||||||||
| Discount rate, % | NaN | |||||||||||||||||||||||||
| PV of cash for distribution, $m | NaN | |||||||||||||||||||||||||
| Current shareholders' claim on cash, % | NaN |